DIFFERIN EPIDUO FDA approval date
The FDA approved DIFFERIN EPIDUO on 22 May 2026.
- FDA approval date
- 22 May 2026
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as ADAPALENE; BENZOYL PEROXIDE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2026-05-22Day | DIFFERIN EPIDUO | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA220736", "applicant_as_listed_by_fda": "GALDERMA LABS LP", "brand_names": ["DIFFERIN EPIDUO", "DIFFERIN EPIDUO ACNE GEL (ADAPALENE AND BENZOYL PEROXIDE)"], "active_ingredients": ["ADAPALENE", "ADAPALENE, BENZOYL PEROXIDE", "BENZOYL PEROXIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260522", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |